TrialBreast cancer research and treatment2017

Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657).

Neelima Vidula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.